Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3557 |  WHWK Whitehawk Therapeutics, Inc. - Common Stock | 3.47 USD | +1.76% | -8.92% | -15.98% | +15.28% | 197.82 M USD | ||
| 3558 |  ACOG Alpha Cognition Inc. - Common Stock | 9.04 USD | 0.00% | +3.91% | +1.23% | +18.48% | 196.87 M USD | ||
| 3560 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 2.42 USD | 0.00% | -2.42% | -12.95% | -18.79% | 196.65 M USD | ||
| 3563 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 70.34 USD | -2.24% | -3.49% | +1.35% | +75.94% | 195.98 M USD | ||
| 3573 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 3.81 USD | +2.14% | +4.38% | -4.51% | -57.53% | 192.61 M USD | ||
| 3606 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 2.51 USD | -1.57% | -4.92% | -32.89% | +36.41% | 179.90 M USD | ||
| 3611 |  DTIL Precision BioSciences, Inc. - Common Stock | 6.43 USD | +2.88% | +0.16% | -10.20% | +9.35% | 177.48 M USD | ||
| 3615 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 4.68 USD | -3.51% | -17.02% | -15.83% | +274.40% | 176.61 M USD | ||
| 3617 |  CMPX Compass Therapeutics, Inc. - Common Stock | 0.98 USD | -3.92% | +4.26% | -54.42% | -75.92% | 176.49 M USD | ||
| 3623 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.20 USD | -3.89% | -7.28% | -11.39% | +76.47% | 174.71 M USD | ||
| 3638 |  PYXS Pyxis Oncology, Inc. - Common Stock | 1.99 USD | -1.00% | -9.95% | -41.81% | -48.04% | 165.98 M USD | ||
| 3641 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 1.57 USD | -3.68% | -4.85% | -19.90% | -37.45% | 165.42 M USD | ||
| 3642 |  CHRS Coherus Oncology, Inc. - Common Stock | 1.07 USD | +5.94% | -10.08% | -19.55% | -33.54% | 165.32 M USD | ||
| 3643 |  PEPG PepGen Inc. - Common Stock | 2.38 USD | -0.83% | +6.25% | -23.96% | -51.43% | 164.84 M USD | ||
| 3648 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.18 USD | +4.42% | -10.61% | -36.22% | -39.18% | 163.17 M USD | ||
| 3652 |  CUE Cue Biopharma, Inc. - Common Stock | 22.33 USD | -0.80% | -12.77% | -26.06% | +2301.08% | 162.21 M USD | ||
| 3664 |  MDWD MediWound Ltd. - Ordinary Shares | 12.42 USD | -3.35% | -8.81% | -9.61% | -33.01% | 159.41 M USD | ||
| 3666 |  NKTX Nkarta, Inc. - Common Stock | 2.22 USD | -2.20% | -14.62% | -22.92% | -5.93% | 159.01 M USD | ||
| 3668 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.37 USD | 0.00% | +2.24% | -17.96% | -69.62% | 158.07 M USD | ||
| 3673 |  TARA Protara Therapeutics, Inc. - Common Stock | 2.65 USD | +2.32% | -5.69% | -30.26% | -53.51% | 156.60 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |